Reduction in Peripheral CD19⁺CD24^hCD27⁺ B Cell Frequency Predicts Favourable Clinical Course in XELOX-Treated Patients with Advanced Gastric Cancer

Publisher： Karger

E-ISSN： 1421-9778|41|5|2045-2052

ISSN： 1015-8987

Source： Cellular Physiology and Biochemistry, Vol.41, Iss.5, 2017-04, pp. : 2045-2052

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunotherapy of B-Cell Lymphoma with an Engineered Bispecific Antibody Targeting CD19 and CD5

By Lüttgau Sandra Deppe Dorothée Meyer Saskia Fertig Regina Panjideh Hossein Lipp Martin Schmetzer Oliver Pezzutto Antonio Breitling Frank Moldenhauer Gerhard

Antibodies, Vol. 2, Iss. 2, 2013-05 ,pp. : 338-352

MDPI

Access to resources Recommend Favorite

Expression of CD40 and CD40L in Gastric Cancer Tissue and Its Clinical Significance

By Li Rui Chen Wei-Chang Pang Xue-Qin Hua Chen Li Ling Zhang Xue-Guang

International Journal of Molecular Sciences, Vol. 10, Iss. 9, 2009-09 ,pp. : 3900-3917

MDPI

Access to resources Recommend Favorite

Prognostic value of circulating CD133+ cells in patients with gastric cancer

CELL PROLIFERATION (ELECTRONIC), Vol. 48, Iss. 3, 2015-06 ,pp. : 311-317

John Wiley & Sons Inc

Access to resources Recommend Favorite

Extracellular Interaction between hCD98 and the PDZ Class II Domain of hCASK in Intestinal Epithelia

By Yan Yutao Vasudevan Sona Nguyen Hang Bork Ulrich Sitaraman Shanthi Merlin Didier

The Journal of Membrane Biology, Vol. 215, Iss. 1, 2007-01 ,pp. : 15-26

Springer Publishing Company

Access to resources Recommend Favorite

Anti-Human Endoglin (hCD105) Immunotoxin—Containing Recombinant Single Chain Ribosome-Inactivating Protein Musarmin 1

By Barriuso Begoña Antolín Pilar Arias F. Javier Girotti Alessandra Jiménez Pilar Cordoba-Diaz Manuel Cordoba-Diaz Damián Girbés Tomás

Toxins, Vol. 8, Iss. 6, 2016-06 ,pp. : 184-184

MDPI

Access to resources Recommend Favorite